ARCHIVES

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Rauscher Says He May Leave, But Will Stay Through June

February 6, 1976

Clinical Trials Approved By NCI In November

December 28, 2001

In Brief: GM Prizes To Withers, Cory, Korsmeyer, Horvitz; Univ. of Chicago, City of Hope Are Comprehensive

May 1, 1998

DCE Recompetition Of Human Tissue Procurement Approved

November 23, 1990

Cancer Training Programs Fairing Fairley Well

December 1, 1989

Wynder Group Finds No Association Between Coffee, Pancreatic Cancer

August 19, 1983